KNSA — KINIKSA PHARMACEUTICALS INTL

Ownership history in ALGERT GLOBAL LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in KINIKSA PHARMACEUTICALS INTL (KNSA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.13% (2025 Q2)
Avg. % of fund
0.07%
First filed
2024 Q2
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 35,847 -196,340 -84.6% 0.02% $1.4M $38.83
2025 Q2 ADDED 232,187 +1,720 +0.7% 0.13% $6.4M $27.67
2025 Q1 ADDED 230,467 +94,653 +69.7% 0.13% $5.1M $22.21
2024 Q4 ADDED 135,814 +44,655 +49.0% 0.06% $2.7M $19.78
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    KNSA price (monthly, adj. close)

Other funds also holding KNSA

As of 2025 Q4 — sorted by position size

TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.6% Fairmount Funds Management LLC 3Y 4.14% Parkman Healthcare Partners LLC 3Y 2.61% Rubric Capital Management LP 3Y 7Y 1.64% ESSEX INVESTMENT MANAGEMENT CO LLC 3Y 7Y 1.58% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 1.35% Soleus Capital Management, L.P. 3Y 0.89% Logos Global Management LP 3Y 0.87% BAKER BROS. ADVISORS LP 3Y 7Y 0.68% GLOBEFLEX CAPITAL L P 3Y 7Y 0.59%
← Back to ALGERT GLOBAL LLC Holdings